Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-070690

SVP, COO & CFO acquired 52,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Labrucherie Gil M SVP, COO & CFO 2021-12-16 Grant or award +52,950 309,182 D
Derivatives
Labrucherie Gil M SVP, COO & CFO 2021-12-16 Grant or award · Stock Option +94,000 94,000 D
Loading xslF345X03/doc4.xml…